Top Players Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, Novartis International AG, Dr. Reddy’s Laboratories Ltd
Active Pharmaceutical ingredients are central ingredient or chemical utilized as a part in manufacturing pharmaceutical medications. It consists of certain steps by procedures, such as chemical synthetic, recombinant DNA or other biotechnology techniques, maturation process, segregation from natural sources or any of these combinations.
Global Active Pharmaceutical Ingredients (API) Market, By Product Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone), Drug (OTC, Rx), Therapy (Diabetes, Oncology, CNS, CVD), Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024
The Global Active Pharmaceutical Ingredients (API) Market accounted to USD 155.1 billion in 2016 growing at a CAGR of 6.50% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2014, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Request for Free Sample of “Global Active Pharmaceutical Ingredients Market” Report Visit @databridgemarketresearch.com/reque…smart-pill-market
Global Active Pharmaceutical Ingredients (API) Major Market Competitors:
Some of the major players operating in active pharmaceutical ingredients (API) market are:
- Teva Pharmaceutical Industries Ltd.
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Novartis International AG
- Reddy’s Laboratories Ltd.
- AbbVie Inc.
- Bristol-Myers Squibb Company
- Pfizer, Inc.
- Eli Lilly and Company
- Boehringer Ingelheim
- Sun Pharmaceutical Industries Limited
- Aurobindo Pharma
- Albemarle Corporation
- Mylan N.V.
Access Report Visit @databridgemarketresearch.com/speak…dients-api-market
Market Segmentation: Global Active Pharmaceutical Ingredients (API) Market
On the basis of product type, Active Pharmaceutical Ingredients (API) market is segmented into innovative and generic product. In 2015 innovative products dominated the market but in future period generic product will dominate growth in the market due to patent expiration of various renowned drugs as the manufacturer facedhuge losses.
On the basis of manufacture, active pharmaceutical ingredients (API) market is segmented into captive and merchant. Here merchant segment will be dominating in forecastperiod because of expansion in outsourcing with different units for the formulation of active drug ingredients and need not to invest in manufacturing sectors.
Based on synthesis, active pharmaceutical ingredients (API) market is segmented into synthetic and biotech. In 2015, synthetic segment was leading with the largest market share.
The rising demand for protein based therapeutics and increase in R&D techniques will definitely contribute towards growth in the forecast period.
On the basis of product, active pharmaceutical ingredients (API)market is segmented intomAb and hormone. Based on drug, active pharmaceutical ingredients (API) market is segmented into OTC and RX.
On the basis of therapy, active pharmaceutical ingredients (API) market is segmented into diabetes, oncology, CNS, and CVD.
On the basis of geography, active pharmaceutical ingredients (API) market report covers data points for 28 countries across multiple geographies such as
- North America & South America
- Middle East & Africa
Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.
Competitive Analysis: Global Active Pharmaceutical Ingredients (API) Market
The Active Pharmaceutical Ingredients (API) Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of active pharmaceutical ingredients (API) market for global, Europe, North America, Asia Pacific and South America.
Major Market Drivers and Restraints: Global Active Pharmaceutical Ingredients (API) Market
- Rising geriatric population
- Expansion in frequency of chronic diseases
- Increment in Abbreviated New Medication Applications (ANDA)
- Growth in technological advancement
- Unfavourable medication value and policies
- Stringent administrative prerequisites
Read Full Report Visit @databridgemarketresearch.com/repor…ients-api-market/
Category: Market Research Publishers and RetailersCompany profile: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...
For more information: